<html xml:lang="en-us" lang="en-us" xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops"><head>
    <link rel="stylesheet" type="text/css" href="../../../../css/base.css" />
<link rel="stylesheet" type="text/css" href="../../../../css/kotobeeInteractive.css" />
<link rel="stylesheet" type="text/css" href="../../../../css/global.css" />
<link rel="stylesheet" type="text/css" href="../css/base.css" />
<link rel="stylesheet" type="text/css" href="../css/global.css" />
<link rel="stylesheet" type="text/css" href="../css/kotobeeInteractive.css" />

    <script type="text/javascript" src="../../../../js/kotobeeInteractive.js"></script>
<script type="text/javascript" src="../../../../js/global.js"></script>
<script type="text/javascript" src="../js/kotobeeInteractive.js"></script>
<script type="text/javascript" src="../js/global.js"></script>

    <title>Ascites</title>
    

<meta name="m-checksum" content="-1056438263" />
<meta charset="utf-8" />
 <meta name="kotobee-chapter" content="epubypzqs\EPUB\xhtml\s6tmtb.xhtml" />
<meta name="kotobee-book" content="urn:uuid:5e546542-c6c7-9ea1-4e90-1d09239f9a56" />
</head>
<body>
<p>Common in both cancer and cirrhosis. Treatment varies depending on the stage and cause of a patient’s illness and may include:</p>

<ol>
	<li>Simple measures (e.g. “no added” dietary salt in patients with cirrhosis)</li>
	<li>Medications (e.g. diuretics)</li>
	<li>Procedures (e.g. ascitic taps - <a class="link296" href="sr4zjy.xhtml">procedure described here</a>)</li>
</ol>

<p>Recurrent ascites in malignancy can be treated with repeat taps or an indwelling drain (e.g. a PleurX catheter, typically&#160;inserted by a radiologist).&#160;The cost of ongoing drainage bottles needs to be considered before insertion.</p>

<p>In liver failure, repeated large volume ascitic taps are often the most straightforward and safest option. Diuretics can be associated with the development of hepatorenal syndrome in patients with cirrhosis and should be used cautiously.</p>

<table>
	<tbody>
		<tr>
			<td><em>Using diuretics for ascites in portal hypertension</em></td>
		</tr>
		<tr>
			<td><strong>Spironolactone</strong></td>
		</tr>
		<tr>
			<td>
			<p>First line agent</p>

			<p>Initial dose: 100mg daily</p>

			<p>Maximum dose: 400mg daily</p>
			</td>
		</tr>
		<tr>
			<td><strong>Furosemide</strong></td>
		</tr>
		<tr>
			<td>
			<p>Second-line agent</p>

			<p>Initial dose: 40mg daily</p>

			<p>Maximum dose: 80mg daily</p>
			</td>
		</tr>
		<tr>
			<td>
			<ul>
				<li>Ensure appropriateness of diuretics by first checking creatinine and electrolytes</li>
				<li>Reduce dose or stop diuretic therapy if creatinine rises &gt; 150 or sodium &gt; 125 or significant potassium abnormalities develop whilst on therapy</li>
			</ul>
			</td>
		</tr>
	</tbody>
</table>

<p>&#160;</p>

<p>&#160;</p>


</body></html>